1. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Issue 10209 (2nd November 2019) Authors: Bachert, Claus; Han, Joseph K; Desrosiers, Martin; Hellings, Peter W; Amin, Nikhil; Lee, Stella E; Mullol, Joaquim; Greos, Leon S; Bosso, John V; Laidlaw, Tanya M; Cervin, Anders U; Maspero, Jorge F; Hopkins, Claire; Olze, Heidi; Canonica, G Walter; Paggiaro, Pierluigi; Cho, Seong H; Fokkens, Wyt... Journal: Lancet Issue: Volume 394:Issue 10209(2019) Page Start: 1638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗